Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Xiaopan Yao"'
Autor:
Eun-Ju Lee, Daniel J. Dykas, Andrew D. Leavitt, Rodney M. Camire, Eduard Ebberink, Pablo García de Frutos, Kavitha Gnanasambandan, Sean X. Gu, James A. Huntington, Steven R. Lentz, Koen Mertens, Christopher R. Parish, Alireza R. Rezaie, Peter P. Sayeski, Caroline Cromwell, Noffar Bar, Stephanie Halene, Natalia Neparidze, Terri L. Parker, Adrienne J. Burns, Anne Dumont, Xiaopan Yao, Cassius Iyad Ochoa Chaar, Jean M. Connors, Allen E. Bale, Alfred Ian Lee
Publikováno v:
Blood Advances, Vol 1, Iss 16, Pp 1224-1237 (2017)
Abstract: Genetics play a significant role in venous thromboembolism (VTE), yet current clinical laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin gene mutation G20210A, or a deficiency of protein C, pr
Externí odkaz:
https://doaj.org/article/c274b1de27734d959984c4c6623722ac
Autor:
Luis Paz‐Ares, David R. Spigel, Yuanbin Chen, Maria Jove, Oscar Juan‐Vidal, Patricia Rich, Theresa Hayes, Vanesa Gutiérrez Calderón, Reyes Bernabe Caro, Alejandro Navarro, Afshin Dowlati, Bin Zhang, Yan Moore, Xiaopan Yao, Jaba Kokhreidze, Santiago Ponce, Paul A. Bunn
Publikováno v:
CANCER
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
RESILIENT (NCT03088813) is a phase 2/3 study assessing the safety, tolerability, and efficacy of liposomal irinotecan monotherapy in patients with small cell lung cancer and disease progression on/after first-line platinum-based therapy. Here, we pre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::680d158944be2a7768767d9b0fb91f2a
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15599
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15599
Autor:
Brent Schultz, Xiaopan Yao, Yanhong Deng, Milton Waner, Christopher Spock, Laura Tom, John Persing, Deepak Narayan
Publikováno v:
PLoS ONE, Vol 10, Iss 10, p e0113168 (2015)
Infantile hemangioma (IH) is the most common tumor of the pediatric age group, affecting up to 4% of newborns ranging from inconsequential blemishes, to highly aggressive tumors. Following well defined growth phases (proliferative, plateau involution
Externí odkaz:
https://doaj.org/article/9855c22c710a4d5dbeeecdd7dc03693a
Autor:
Vamsidhar Velcheti, Kurt Schalper, Xiaopan Yao, Huan Cheng, Mehmet Kocoglu, Kavita Dhodapkar, Yanhong Deng, Scott Gettinger, David L Rimm
Publikováno v:
PLoS ONE, Vol 8, Iss 4, p e61427 (2013)
BACKGROUND: SOX2 is an embryonic developmental transcription factor, which is important in the development of the respiratory tract. SOX2 overexpression is associated with aggressive disease in several tumor types. However, SOX2 overexpression and ge
Externí odkaz:
https://doaj.org/article/9750650890124d03991aafc84a2d4304
Autor:
Wendy B. London, Mitali Basu, Tomoyuki Mizuno, Sanjay P. Prabhu, Jay B. Pietrantonio, Lianne Greenspan, Jeffrey C. Allen, Stephen P. Hunger, Jennifer Direnzo, Pei Chi Kao, Joseph Destefano, Susan N. Chi, Karen Wright, Alexander A. Vinks, Danielle Cassidy, Xiaopan Yao, Jessica Boklan, Tanya M. Trippett, Cynthia E. Herzog, Kellie Nazemi, Lia Gore, Kenneth J. Cohen, Matthias A. Karajannis, Amy Smith, Howard M. Katzenstein, John P. Perentesis, Russ Geyer, Mark W. Kieran, Debra Schissel
Publikováno v:
Pediatr Blood Cancer
Background To evaluate efficacy, pharmacokinetics (PK) and pharmacodynamics of single-agent everolimus in pediatric patients with radiographically progressive low-grade glioma (LGG). Methods Everolimus was administered at 5 mg/m2 once daily as a tabl
Autor:
Frank C. Detterbeck, Joseph B. Shrager, Heather A. Wakelee, Sukhmani K. Padda, James Huang, Xiaopan Yao, Robert J. Korst, Sunil S. Badve, Bryan M. Burt, Alberto Antonicelli, Jonathan W. Riess, Yue Shang
Publikováno v:
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol 13, iss 3
IntroductionThymic epithelial tumors (TETs) are associated with paraneoplastic/autoimmune (PN/AI) syndromes. Myasthenia gravis is the most common PN/AI syndrome associated with TETs.MethodsThe International Thymic Malignancy Interest Group retrospect
Autor:
Samuel Kim, Glenda G. Callender, Derek Toomre, Nathalie Abitbol, Julie Ann Sosa, Xiaopan Yao, Felix Rivera-Molina, Alexander Y. Li, Fangyong Li, Niclas Broer, Sanziana A. Roman, Deepak Narayan, Christine A. Simpson, Gloria R. Sue, Don Hoang
Publikováno v:
Annals of Surgery. 266:1075-1083
Objective We asked if leptin and its cognate receptor were present in normal and diseased parathyroid glands, and if so, whether they had any functional effects on parathyroid hormone (PTH) secretion in parathyroid neoplasms. Background The parathyro
Autor:
Eric Vallières, Yue Shang, Brian E. Louie, Alberto Antonicelli, Ralph W. Aye, Alexander S. Farivar, Zhitao Gu, Wentao Fang, Frank C. Detterbeck, James Huang, Xiaopan Yao
Publikováno v:
European Journal of Cardio-Thoracic Surgery. 52:26-32
OBJECTIVES Surgeons at different institutions worldwide choose different types of operations for thymic tumours. It is not known whether these differences affect the outcomes of the patients. METHODS A total of 1430 patients with Masaoka-Koga patholo
Autor:
Andreas Rimner, James Huang, Robert J. Korst, Daniel R. Gomez, Xiaopan Yao, Frank C. Detterbeck, Alberto Antonicelli, Usman Ahmad
Publikováno v:
Journal of Thoracic Oncology. 11:1785-1792
Objectives The aim of this study was to determine whether postoperative radiation therapy (PORT) is associated with an overall survival (OS) benefit in patients with completely resected Masaoka or Masaoka-Koga stage II and III thymoma. Methods All pa
Autor:
Xiaopan Yao, Matthew Madura, Upendra P. Hegde, Lucia B. Jilaveanu, Elin Rowen, Amit Mahajan, Mario Sznol, Stephanie Speaker, Heather Gerrish, Angel Rivera, James B. Yu, Amanda Ralabate, Veronica Chiang, Apostolos John Tsiouris, Anne C. Chiang, Harriet M. Kluger, Scott N. Gettinger, Justine V. Cohen, Roy S. Herbst, Alexander O. Vortmeyer, Sarah B. Goldberg
Publikováno v:
The Lancet Oncology. 17:976-983
Summary Background Immunotherapy targeting the PD-1 axis has activity in several tumour types. We aimed to establish the activity and safety of the PD-1 inhibitor pembrolizumab in patients with untreated brain metastases from melanoma or non-small-ce